Walleye Trading LLC Sage Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $235,980 - $307,188	13,800 Added 1380.0%	14,800 $320,000
Q3 2023 Nov 14, 2023	SELL	$16.75 - $48.98 $301,500 - $881,640	-18,000 Reduced 94.74%	1,000 $20,000
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $715,440 - $1.05 Million	17,600 Added 1257.14%	19,000 $893,000
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $81,994 - $102,454	-2,200 Reduced 61.11%	1,400 $58,000
Q4 2022 Feb 14, 2023	BUY	$32.2 - $43.61 $115,920 - $156,996	3,600 New	3,600 $137,000
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $181,594 - $230,839	-4,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $100,650 - $143,425	2,500 Added 104.17%	4,900 $217,000
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $669,536 - $967,338	-12,200 Reduced 83.56%	2,400 $136,000
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $586,395 - $803,108	8,300 Added 131.75%	14,600 $1.09 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $525,690 - $801,540	-9,000 Reduced 58.82%	6,300 $545,000
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $358,110 - $595,470	13,800 Added 920.0%	15,300 $636,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $49,685 - $146,756	-1,900 Reduced 55.88%	1,500 $43,000
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $367,098 - $944,097	-6,100 Reduced 64.21%	3,400 $245,000
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $1.71 Million - $2.32 Million	-12,200 Reduced 56.22%	9,500 $1.33 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $3.43 Million - $3.97 Million	21,700 New	21,700 $3.97 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $557,192 - $950,028	-6,800 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $939,148 - $1.15 Million	6,800 New	6,800 $961,000

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account